End-stage renal disease in patients with Fabry disease

被引：19
|
作者：
Obrador, GT
Ojo, A
Thadhani, R
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA
[2] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA
[3] Panamer Univ, Sch Med, Mexico City, DF, Mexico
[4] Univ Michigan, Dept Nephrol, Ann Arbor, MI USA
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 06期
关键词：
D O I：
10.1097/01.ASN.0000015237.87719.DC
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S144 / S146
页数：3
相关论文
共 50 条
  • [1] End-stage renal disease in Fabry disease
    Granata, A.
    Romeo, G.
    Gulisano, S.
    Leonardi, G.
    Romano, R.
    Manca, E.
    Fiumara, A.
    Sicurezza, E.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : S20 - S20
  • [2] MORTALITY IN PATIENTS WITH FABRY DISEASE AND END-STAGE RENAL FAILURE
    Karovaikina, Ekaterina
    Moiseev, Sergey
    Bulanov, Nikolay
    Moiseev, Alexey
    Kuchieva, Agunda
    Fomin, Viktor
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 371 - 371
  • [3] Enzyme replacement therapy in patients with Fabry disease and end-stage renal disease
    [J]. Nature Clinical Practice Nephrology, 2007, 3 (10): : 525 - 526
  • [4] Prevalence of end-stage renal failure in patients diagnosed with Fabry disease
    Franco, A.
    Torras, J.
    Torra, R.
    Valverde, V.
    Herrera, J.
    Pintos-Morell, G.
    Paniagua, J.
    Gomez, E.
    Torregosa, V.
    Hernandez, S.
    West, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 : S137 - S138
  • [5] End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry
    Ortiz, Alberto
    Cianciaruso, Bruno
    Cizmarik, Marta
    Germain, Dominique P.
    Mignani, Renzo
    Oliveira, Joao Paulo
    Villalobos, Jacobo
    Vujkovac, Bojan
    Waldek, Stephen
    Wanner, Christoph
    Warnock, David G.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (03) : 769 - 775
  • [6] Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease
    Pastores, Gregory M.
    Boyd, Ellen
    Crandall, Kerry
    Whelan, Alison
    Piersall, Linda
    Barnett, Natalie
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (07) : 1920 - 1925
  • [7] Screening for Fabry disease in male patients with end-stage renal disease in western France
    Vigneau, C.
    Germain, D. P.
    Larmet, D.
    Jabbour, F.
    Hourmant, M.
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2021, 17 (03): : 180 - 184
  • [8] Fabry disease in patients with end-stage renal failure: The potential benefits of screening
    Bekri, S
    Enica, A
    Ghafari, T
    Plaza, G
    Champenois, I
    Choukroun, G
    Unwin, R
    Jaeger, P
    [J]. NEPHRON CLINICAL PRACTICE, 2005, 101 (01): : C33 - C38
  • [9] NATURAL HISTORY OF END-STAGE RENAL DISEASE IN PATIENTS ENROLLED IN THE FABRY REGISTRY
    Ortiz, Alberto
    Cianciaruso, Bruno
    Cizmarik, Marta
    Germain, Dominique P.
    Mignani, Renzo
    Oliveira, Joao Paulo
    Villalobos, Jacobo
    Vujkovac, Bojan
    Waldek, Stephen
    Wanner, Christoph
    Warnock, David G.
    [J]. CLINICAL THERAPEUTICS, 2010, 32 : S104 - S104
  • [10] Cardiovascular disease in end-stage renal disease patients
    Collins, AJ
    Li, SL
    Ma, JZ
    Herzog, C
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S26 - S29
12345